Literature DB >> 11768814

Advanced age does not contribute to increased risks or poor outcome after major abdominal operations.

S L Blair1, R E Schwarz.   

Abstract

Elderly patients are still frequently denied major operations out of concerns over increased morbidity. The impact of advanced age on morbidity, mortality, and late outcomes after major gastric and pancreatic resections was studied by retrospective review with Chi square and regression analysis. Between July 1987 and June 2000, 179 patients underwent a major gastrectomy or pancreatectomy procedure at the City of Hope Cancer Center. There were 96 males and 83 females with a median age of 64 years (range 17-97) and elderly subsets more than 70 (n = 53) and more than 80 (n = 18) years of age. Diagnoses included gastric cancer (n = 83, 46%), pancreatic or periampullary cancer (n = 78, 44%), and benign pancreatic (n = 11, 6%) or gastric (n = 7, 4%) conditions. Age >70 years was correlated with more complex underlying medical conditions (P = 0.001) and gastrectomy for cancer (P = 0.01). None of four in-hospital deaths or 11 90-day lethal events occurred in patients >70 years of age (P = 0.005). Overall complications (35% vs 49%) and major complications (25% vs 37%) were less frequent in the older patient group [P = not significant (NS)]. Median intensive care unit stay (3 vs 2 days) and hospital stay (12 vs 12.5 days) were similar (P = NS). Pancreatoduodenectomy, gastrectomy for "benign" indications, and splenectomy--but not age--were significant prognostic variables for increased complications and longer hospital stay (at P < 0.05). At a median follow-up of 13 months (20 for survivors) the median survival after resection for gastric cancer (30 vs 16 months) or pancreatic/periampullary cancer (30 vs 23 months) was not inferior in elderly patients (P = NS). Five-year disease-free survival was superior in gastric cancer patients >70 years (59% vs 26%, P = 0.03) but not for pancreatic cancer. Advanced age under current clinical selection criteria does not impose increased hazards beyond disease- and procedure-related risk factors for patients undergoing gastrectomy or pancreatectomy; no patient should be denied these operations on the basis of age criteria alone.

Entities:  

Mesh:

Year:  2001        PMID: 11768814

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  6 in total

1.  Safe major abdominal operations: hepatectomy, gastrectomy and pancreatoduodenectomy in elder patients.

Authors:  Yu-Lian Wu; Jun-Xiu Yu; Bin Xu
Journal:  World J Gastroenterol       Date:  2004-07-01       Impact factor: 5.742

2.  Clinicopathological features of gastric carcinoma in younger and middle-aged patients: a comparative study.

Authors:  Chikara Kunisaki; Hirotoshi Akiyama; Masato Nomura; Goro Matsuda; Yuichi Otsuka; Hidetaka Andrew Ono; Ryo Takagawa; Yutaka Nagahori; Masazumi Takahashi; Fumihiko Kito; Hiroshi Shimada
Journal:  J Gastrointest Surg       Date:  2006 Jul-Aug       Impact factor: 3.452

3.  Practical questions in liver metastases of colorectal cancer: general principles of treatment.

Authors:  Héctor Daniel González; Joan Figueras
Journal:  HPB (Oxford)       Date:  2007       Impact factor: 3.647

4.  The effect of age on short-term and mid-term outcomes after thoracoscopic Ivor Lewis esophagectomy: a propensity score-matched analysis.

Authors:  Friederike Martin; Dino Kröll; Sebastian Knitter; Tobias Hofmann; Jonas Raakow; Christian Denecke; Johann Pratschke; Matthias Biebl
Journal:  BMC Surg       Date:  2021-12-20       Impact factor: 2.102

5.  Surgical treatment of liver metastases from colorectal carcinoma in elderly patients. When is it worthwhile?

Authors:  J Figueras; E Ramos; S López-Ben; J Torras; M Albiol; L Llado; H D González; A Rafecas
Journal:  Clin Transl Oncol       Date:  2007-06       Impact factor: 3.340

Review 6.  Laparoscopic hepatectomy for elderly patients: Major findings based on a systematic review and meta-analysis.

Authors:  Ke Chen; Yu Pan; Hendi Maher; Bin Zhang; Xue-Yong Zheng
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.